HUP0201262A3 - Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives - Google Patents
Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivativesInfo
- Publication number
- HUP0201262A3 HUP0201262A3 HU0201262A HUP0201262A HUP0201262A3 HU P0201262 A3 HUP0201262 A3 HU P0201262A3 HU 0201262 A HU0201262 A HU 0201262A HU P0201262 A HUP0201262 A HU P0201262A HU P0201262 A3 HUP0201262 A3 HU P0201262A3
- Authority
- HU
- Hungary
- Prior art keywords
- piperidinyl
- betha
- oxo
- carbonyl
- propyl
- Prior art date
Links
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12567199P | 1999-03-22 | 1999-03-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0201262D0 HU0201262D0 (hu) | 2002-05-29 |
| HUP0201262A2 HUP0201262A2 (en) | 2002-08-28 |
| HUP0201262A3 true HUP0201262A3 (en) | 2003-12-29 |
Family
ID=22420863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201262A HUP0201262A3 (en) | 1999-03-22 | 2000-03-21 | Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6515130B1 (hu) |
| EP (1) | EP1165543B1 (hu) |
| JP (1) | JP2002540108A (hu) |
| KR (1) | KR20020019895A (hu) |
| CN (1) | CN1351600A (hu) |
| AT (1) | ATE242235T1 (hu) |
| AU (1) | AU775413B2 (hu) |
| BR (1) | BR0010652A (hu) |
| CA (1) | CA2368024A1 (hu) |
| CZ (1) | CZ20013431A3 (hu) |
| DE (1) | DE60003169T2 (hu) |
| DK (1) | DK1165543T3 (hu) |
| ES (1) | ES2199805T3 (hu) |
| HK (1) | HK1046272A1 (hu) |
| HR (1) | HRP20010767A2 (hu) |
| HU (1) | HUP0201262A3 (hu) |
| MX (1) | MXPA01009615A (hu) |
| PT (1) | PT1165543E (hu) |
| SK (1) | SK13562001A3 (hu) |
| UA (1) | UA67832C2 (hu) |
| WO (1) | WO2000056730A1 (hu) |
| YU (1) | YU74601A (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0009856A (pt) | 1999-03-22 | 2002-02-05 | Ortho Mcneil Pharm Inc | Sìntese de 3-amino-3-aril propanoatos |
| DK1430057T3 (da) * | 2001-09-21 | 2006-01-16 | Sanofi Aventis | Substituerede 2-pyridinyl-6,7,8, 9-tetrahydropyrimido [1,2-a] pyrimidin-4-on- og 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)onderivater |
| WO2013023795A1 (en) | 2011-08-17 | 2013-02-21 | Piramal Imaging Sa | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
| EP2956461A1 (en) | 2013-02-12 | 2015-12-23 | Bayer Pharma Aktiengesellschaft | Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia |
| KR102236806B1 (ko) | 2013-02-20 | 2021-04-06 | 로이터 케미쉐 아파라테바우 이.카. | 거울상 이성질체 농후화된 3-아미노피페리딘의 제조 방법 |
| WO2014173855A1 (en) | 2013-04-22 | 2014-10-30 | Reuter Chemische Apparatebau Kg | Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58243B1 (en) | 1983-12-07 | 1993-08-11 | Lonza Ag | A process for the preparation of optically-active 3-amino carboxylic acids |
| US5254573A (en) | 1991-10-15 | 1993-10-19 | Monsanto Company | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| US6380215B1 (en) * | 1993-09-22 | 2002-04-30 | Fujisawa Pharmaceutical Co., Ltd | Beta-alanine derivative and a process for the preparation thereof |
| US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
| WO1997033869A1 (en) * | 1996-03-13 | 1997-09-18 | Fujisawa Pharmaceutical Co., Ltd. | N-[(r)-1-{3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
| ATE421952T1 (de) | 1996-05-01 | 2009-02-15 | Ortho Mcneil Pharm Inc | Carboxamidderivate von pyrrolidin, piperidin und hexahydropiperizin für behandlung von thrombosen |
| CN1119321C (zh) | 1996-07-12 | 2003-08-27 | G·D·瑟尔公司 | 手性β－氨基酸的不对称合成 |
| US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
-
2000
- 2000-03-21 UA UA2001096538A patent/UA67832C2/uk unknown
- 2000-03-21 AT AT00916573T patent/ATE242235T1/de not_active IP Right Cessation
- 2000-03-21 DE DE60003169T patent/DE60003169T2/de not_active Expired - Fee Related
- 2000-03-21 DK DK00916573T patent/DK1165543T3/da active
- 2000-03-21 CZ CZ20013431A patent/CZ20013431A3/cs unknown
- 2000-03-21 JP JP2000606591A patent/JP2002540108A/ja active Pending
- 2000-03-21 AU AU37661/00A patent/AU775413B2/en not_active Ceased
- 2000-03-21 EP EP00916573A patent/EP1165543B1/en not_active Expired - Lifetime
- 2000-03-21 KR KR1020017012100A patent/KR20020019895A/ko not_active Application Discontinuation
- 2000-03-21 CA CA002368024A patent/CA2368024A1/en not_active Abandoned
- 2000-03-21 CN CN00807617A patent/CN1351600A/zh active Pending
- 2000-03-21 YU YU74601A patent/YU74601A/sh unknown
- 2000-03-21 ES ES00916573T patent/ES2199805T3/es not_active Expired - Lifetime
- 2000-03-21 BR BR0010652-6A patent/BR0010652A/pt not_active IP Right Cessation
- 2000-03-21 MX MXPA01009615A patent/MXPA01009615A/es unknown
- 2000-03-21 HU HU0201262A patent/HUP0201262A3/hu unknown
- 2000-03-21 US US09/532,375 patent/US6515130B1/en not_active Expired - Lifetime
- 2000-03-21 SK SK1356-2001A patent/SK13562001A3/sk unknown
- 2000-03-21 WO PCT/US2000/007462 patent/WO2000056730A1/en not_active Application Discontinuation
- 2000-03-21 PT PT00916573T patent/PT1165543E/pt unknown
-
2001
- 2001-10-19 HR HR20010767A patent/HRP20010767A2/hr not_active Application Discontinuation
-
2002
- 2002-02-22 US US10/081,289 patent/US20020137937A1/en not_active Abandoned
- 2002-10-15 HK HK02107463.1A patent/HK1046272A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1165543T3 (da) | 2003-09-29 |
| CN1351600A (zh) | 2002-05-29 |
| ATE242235T1 (de) | 2003-06-15 |
| HUP0201262A2 (en) | 2002-08-28 |
| CZ20013431A3 (cs) | 2003-04-16 |
| ES2199805T3 (es) | 2004-03-01 |
| HK1046272A1 (zh) | 2003-01-03 |
| HRP20010767A2 (en) | 2002-12-31 |
| DE60003169D1 (de) | 2003-07-10 |
| JP2002540108A (ja) | 2002-11-26 |
| EP1165543B1 (en) | 2003-06-04 |
| HU0201262D0 (hu) | 2002-05-29 |
| EP1165543A1 (en) | 2002-01-02 |
| DE60003169T2 (de) | 2005-10-27 |
| PT1165543E (pt) | 2003-10-31 |
| US20020137937A1 (en) | 2002-09-26 |
| SK13562001A3 (sk) | 2002-08-06 |
| AU3766100A (en) | 2000-10-09 |
| KR20020019895A (ko) | 2002-03-13 |
| WO2000056730A1 (en) | 2000-09-28 |
| AU775413B2 (en) | 2004-07-29 |
| UA67832C2 (uk) | 2004-07-15 |
| US6515130B1 (en) | 2003-02-04 |
| BR0010652A (pt) | 2002-07-16 |
| CA2368024A1 (en) | 2000-09-28 |
| MXPA01009615A (es) | 2003-07-21 |
| YU74601A (sh) | 2004-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1100562A1 (en) | Process for preparing amine platinum complexes | |
| IL150542A0 (en) | Method for preparing hydroxypicolinic acid derivatives | |
| IL126264A0 (en) | Process for preparing lactic acid | |
| DE50003632D1 (de) | Verfahren zur herstellung von l-phenylephrinhydrochlorid | |
| HUP0004884A3 (en) | Process for preparing 1,4-dihydropyridine derivatives | |
| HUP0201262A3 (en) | Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives | |
| IL148330A0 (en) | Process for preparing phenylacetic acid derivatives | |
| HUP0203159A3 (en) | Method for producing liposome preparation, containing pipecolic acid derivative | |
| HUP0105200A3 (en) | Method for preparing methyl carbazate | |
| TWI318213B (en) | Polyamide nucleic acid derivatives, and agents and processes for preparing them | |
| IL144363A0 (en) | (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same | |
| HUP0201418A2 (en) | Process for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or from a derative thereof | |
| SG83788A1 (en) | Method for preparing polymer | |
| IL142341A0 (en) | Process for preparing 1,5-diaryl-3-substituted pyrazoles | |
| SI1165543T1 (en) | PROCESS FOR PREPARING S-(R*,S*)) -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL) -3-PIPERIDINYL) CARBONYL) AMINO) -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES | |
| IL135243A (en) | Process for preparing cyclic thioamides | |
| HUP0201353A3 (en) | Processes for preparing optically active amino acid derivatives | |
| HUP0000559A3 (en) | Process for preparing cyanoaceticacidesters | |
| PL356988A1 (en) | Method for making adipic acid | |
| AU1525301A (en) | Process for preparing improved protein hydrolysates | |
| AU2860201A (en) | Method for preparing guar gum oligomers | |
| ZA200005017B (en) | 1-[1-substituted-4-piperidnyl)methyl]-4-piperidine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermidiate therefor. | |
| GB9917291D0 (en) | Process for preparing polymers | |
| HU0001928D0 (en) | Process for preparing 2-phenyl-3-aminopyridine, substituted phenyl derivatives thereof and salts thereof |